ECONOMIC EVALUATION OF CYP2C19 GENOTYPE-GUIDED ANTIPLATELET THERAPY FOR PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A SYSTEMATIC REVIEW. GLOBEHEAL 2026, 9 (01), 14-30. https://doi.org/10.17501/26138417.2026.9102.